预计扭亏！这家公司终止重大资产重组！

Core Viewpoint - Nanhua Biomedical Co., Ltd. has officially terminated its major asset restructuring plan after nearly six months of planning due to a lack of consensus among the parties involved in the transaction [1][7]. Group 1: Company Background and Performance - The company, formerly known as Hong Kong and Macau Industry, was listed in 1992 and has undergone multiple ownership changes and name changes, finally being renamed "Nanhua Biomedical" in 2015 to enter the biomedical field [4]. - The company has two main businesses: "biomedical" (stem cell and immune cell storage) and "energy conservation and environmental protection," but its performance has been inconsistent, with revenue heavily reliant on cell storage [4]. - The company has oscillated between being under special treatment (ST) and being delisted due to continuous losses, with the most recent instance of being under ST occurring in 2019 [4][5]. Group 2: Termination of Restructuring - The planned acquisition of a 51% stake in Hunan Huize Biomedical Technology Co., Ltd. was intended to expand the biomedical sector but was ultimately terminated due to failure to reach an agreement on the transaction plan [6][7]. - The termination of the restructuring will not have a significant adverse impact on the company's production, operations, or financial status, as it was still in the planning stage and had not entered formal implementation [7][8]. Group 3: Financial Performance and Future Outlook - The company has projected a significant increase in revenue for 2025, estimating between 385 million to 425 million yuan, compared to approximately 130 million yuan in the previous year [10]. - The net profit attributable to shareholders is expected to be between 28.5 million to 32.5 million yuan, marking a turnaround from a loss of 19.846 million yuan in the previous year [11]. - The improvement in financial performance is primarily attributed to the acquisition of Loudi Jinhong New Materials Co., Ltd., which has enhanced revenue from resource recycling businesses [13][14]. - The company is also expanding its product offerings related to its biomedical and environmental protection businesses, contributing to revenue and profit growth [15][16].